AAV8-delivered TTR-specific ARCUS meganuclease (Precision BioSciences)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAAV8-delivered TTR-specific ARCUS meganuclease (Precision BioSciences)

Drug Alias NameTTR-specific meganuclease (Precision BioSciences)

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vectorBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionTransthyretin inhibitors

TargetsTransthyretin

Therapy Area/IndicationsPolyneuropathies

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPrecision Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPrecision Biosciences Inc

Active IndicationsN/A

Inactive IndicationsPolyneuropathies

Other Information

ATC CodeN/A